TCL Archive Reinventing NCI: clinical Trials report Calls for Study Section, increased Funding For Cooperative Groups October 3, 1997
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013